Interleukin 16 expression changes in association with ovarian malignant transformation
Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development.
Gespeichert in:
| Autor*in: |
Yellapa, Aparna [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
24490 |
|---|
| Übergeordnetes Werk: |
Enthalten in: IS - Domingues, Sara ELSEVIER, 2018, AJOG, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:210 ; year:2014 ; number:3 ; pages:2721-27210 ; extent:24490 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ajog.2013.12.041 |
|---|
| Katalog-ID: |
ELV017919665 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV017919665 | ||
| 003 | DE-627 | ||
| 005 | 20230623141115.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajog.2013.12.041 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014019000017.pica |
| 035 | |a (DE-627)ELV017919665 | ||
| 035 | |a (ELSEVIER)S0002-9378(13)02286-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 100 | 1 | |a Yellapa, Aparna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Interleukin 16 expression changes in association with ovarian malignant transformation |
| 264 | 1 | |c 2014 | |
| 300 | |a 24490 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. | ||
| 650 | 7 | |a interleukin 16 |2 Elsevier | |
| 650 | 7 | |a malignant transformation |2 Elsevier | |
| 650 | 7 | |a ovarian cancer |2 Elsevier | |
| 650 | 7 | |a laying hen model |2 Elsevier | |
| 700 | 1 | |a Bitterman, Pincas |4 oth | |
| 700 | 1 | |a Sharma, Sameer |4 oth | |
| 700 | 1 | |a Guirguis, Alfred S. |4 oth | |
| 700 | 1 | |a Bahr, Janice M. |4 oth | |
| 700 | 1 | |a Basu, Sanjib |4 oth | |
| 700 | 1 | |a Abramowicz, Jacques S. |4 oth | |
| 700 | 1 | |a Barua, Animesh |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Domingues, Sara ELSEVIER |t IS |d 2018 |d AJOG |g Orlando, Fla |w (DE-627)ELV000288284 |
| 773 | 1 | 8 | |g volume:210 |g year:2014 |g number:3 |g pages:2721-27210 |g extent:24490 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajog.2013.12.041 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 210 |j 2014 |e 3 |h 2721-27210 |g 24490 |y 210.2014, 3, 272.e1-, (24490 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
a y ay |
|---|---|
| matchkey_str |
yellapaaparnabittermanpincassharmasameer:2014----:nelui1epesocagsnsoitowtoaina |
| hierarchy_sort_str |
2014 |
| publishDate |
2014 |
| allfields |
10.1016/j.ajog.2013.12.041 doi GBVA2014019000017.pica (DE-627)ELV017919665 (ELSEVIER)S0002-9378(13)02286-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Yellapa, Aparna verfasserin aut Interleukin 16 expression changes in association with ovarian malignant transformation 2014 24490 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model Elsevier Bitterman, Pincas oth Sharma, Sameer oth Guirguis, Alfred S. oth Bahr, Janice M. oth Basu, Sanjib oth Abramowicz, Jacques S. oth Barua, Animesh oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:210 year:2014 number:3 pages:2721-27210 extent:24490 https://doi.org/10.1016/j.ajog.2013.12.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 210 2014 3 2721-27210 24490 210.2014, 3, 272.e1-, (24490 S.) 045F 610 |
| spelling |
10.1016/j.ajog.2013.12.041 doi GBVA2014019000017.pica (DE-627)ELV017919665 (ELSEVIER)S0002-9378(13)02286-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Yellapa, Aparna verfasserin aut Interleukin 16 expression changes in association with ovarian malignant transformation 2014 24490 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model Elsevier Bitterman, Pincas oth Sharma, Sameer oth Guirguis, Alfred S. oth Bahr, Janice M. oth Basu, Sanjib oth Abramowicz, Jacques S. oth Barua, Animesh oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:210 year:2014 number:3 pages:2721-27210 extent:24490 https://doi.org/10.1016/j.ajog.2013.12.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 210 2014 3 2721-27210 24490 210.2014, 3, 272.e1-, (24490 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.ajog.2013.12.041 doi GBVA2014019000017.pica (DE-627)ELV017919665 (ELSEVIER)S0002-9378(13)02286-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Yellapa, Aparna verfasserin aut Interleukin 16 expression changes in association with ovarian malignant transformation 2014 24490 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model Elsevier Bitterman, Pincas oth Sharma, Sameer oth Guirguis, Alfred S. oth Bahr, Janice M. oth Basu, Sanjib oth Abramowicz, Jacques S. oth Barua, Animesh oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:210 year:2014 number:3 pages:2721-27210 extent:24490 https://doi.org/10.1016/j.ajog.2013.12.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 210 2014 3 2721-27210 24490 210.2014, 3, 272.e1-, (24490 S.) 045F 610 |
| allfieldsGer |
10.1016/j.ajog.2013.12.041 doi GBVA2014019000017.pica (DE-627)ELV017919665 (ELSEVIER)S0002-9378(13)02286-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Yellapa, Aparna verfasserin aut Interleukin 16 expression changes in association with ovarian malignant transformation 2014 24490 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model Elsevier Bitterman, Pincas oth Sharma, Sameer oth Guirguis, Alfred S. oth Bahr, Janice M. oth Basu, Sanjib oth Abramowicz, Jacques S. oth Barua, Animesh oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:210 year:2014 number:3 pages:2721-27210 extent:24490 https://doi.org/10.1016/j.ajog.2013.12.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 210 2014 3 2721-27210 24490 210.2014, 3, 272.e1-, (24490 S.) 045F 610 |
| allfieldsSound |
10.1016/j.ajog.2013.12.041 doi GBVA2014019000017.pica (DE-627)ELV017919665 (ELSEVIER)S0002-9378(13)02286-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Yellapa, Aparna verfasserin aut Interleukin 16 expression changes in association with ovarian malignant transformation 2014 24490 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model Elsevier Bitterman, Pincas oth Sharma, Sameer oth Guirguis, Alfred S. oth Bahr, Janice M. oth Basu, Sanjib oth Abramowicz, Jacques S. oth Barua, Animesh oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:210 year:2014 number:3 pages:2721-27210 extent:24490 https://doi.org/10.1016/j.ajog.2013.12.041 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 210 2014 3 2721-27210 24490 210.2014, 3, 272.e1-, (24490 S.) 045F 610 |
| language |
English |
| source |
Enthalten in IS Orlando, Fla volume:210 year:2014 number:3 pages:2721-27210 extent:24490 |
| sourceStr |
Enthalten in IS Orlando, Fla volume:210 year:2014 number:3 pages:2721-27210 extent:24490 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
interleukin 16 malignant transformation ovarian cancer laying hen model |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
IS |
| authorswithroles_txt_mv |
Yellapa, Aparna @@aut@@ Bitterman, Pincas @@oth@@ Sharma, Sameer @@oth@@ Guirguis, Alfred S. @@oth@@ Bahr, Janice M. @@oth@@ Basu, Sanjib @@oth@@ Abramowicz, Jacques S. @@oth@@ Barua, Animesh @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000288284 |
| dewey-sort |
3610 |
| id |
ELV017919665 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017919665</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623141115.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2013.12.041</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014019000017.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017919665</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(13)02286-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yellapa, Aparna</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Interleukin 16 expression changes in association with ovarian malignant transformation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">24490</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">interleukin 16</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">malignant transformation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ovarian cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">laying hen model</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bitterman, Pincas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharma, Sameer</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guirguis, Alfred S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bahr, Janice M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Basu, Sanjib</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abramowicz, Jacques S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barua, Animesh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:210</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:2721-27210</subfield><subfield code="g">extent:24490</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2013.12.041</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">210</subfield><subfield code="j">2014</subfield><subfield code="e">3</subfield><subfield code="h">2721-27210</subfield><subfield code="g">24490</subfield><subfield code="y">210.2014, 3, 272.e1-, (24490 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Yellapa, Aparna |
| spellingShingle |
Yellapa, Aparna ddc 610 ddc 570 fid BIODIV Elsevier interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model Interleukin 16 expression changes in association with ovarian malignant transformation |
| authorStr |
Yellapa, Aparna |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000288284 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 570 VZ BIODIV DE-30 fid Interleukin 16 expression changes in association with ovarian malignant transformation interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model Elsevier |
| topic |
ddc 610 ddc 570 fid BIODIV Elsevier interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model |
| topic_unstemmed |
ddc 610 ddc 570 fid BIODIV Elsevier interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model |
| topic_browse |
ddc 610 ddc 570 fid BIODIV Elsevier interleukin 16 Elsevier malignant transformation Elsevier ovarian cancer Elsevier laying hen model |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
p b pb s s ss a s g as asg j m b jm jmb s b sb j s a js jsa a b ab |
| hierarchy_parent_title |
IS |
| hierarchy_parent_id |
ELV000288284 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
| hierarchy_top_title |
IS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000288284 |
| title |
Interleukin 16 expression changes in association with ovarian malignant transformation |
| ctrlnum |
(DE-627)ELV017919665 (ELSEVIER)S0002-9378(13)02286-2 |
| title_full |
Interleukin 16 expression changes in association with ovarian malignant transformation |
| author_sort |
Yellapa, Aparna |
| journal |
IS |
| journalStr |
IS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
2721 |
| author_browse |
Yellapa, Aparna |
| container_volume |
210 |
| physical |
24490 |
| class |
610 610 DE-600 570 VZ BIODIV DE-30 fid |
| format_se |
Elektronische Aufsätze |
| author-letter |
Yellapa, Aparna |
| doi_str_mv |
10.1016/j.ajog.2013.12.041 |
| dewey-full |
610 570 |
| title_sort |
interleukin 16 expression changes in association with ovarian malignant transformation |
| title_auth |
Interleukin 16 expression changes in association with ovarian malignant transformation |
| abstract |
Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. |
| abstractGer |
Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. |
| abstract_unstemmed |
Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
3 |
| title_short |
Interleukin 16 expression changes in association with ovarian malignant transformation |
| url |
https://doi.org/10.1016/j.ajog.2013.12.041 |
| remote_bool |
true |
| author2 |
Bitterman, Pincas Sharma, Sameer Guirguis, Alfred S. Bahr, Janice M. Basu, Sanjib Abramowicz, Jacques S. Barua, Animesh |
| author2Str |
Bitterman, Pincas Sharma, Sameer Guirguis, Alfred S. Bahr, Janice M. Basu, Sanjib Abramowicz, Jacques S. Barua, Animesh |
| ppnlink |
ELV000288284 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ajog.2013.12.041 |
| up_date |
2024-07-06T17:31:09.594Z |
| _version_ |
1803851734288695296 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017919665</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623141115.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2013.12.041</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014019000017.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017919665</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(13)02286-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yellapa, Aparna</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Interleukin 16 expression changes in association with ovarian malignant transformation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">24490</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Long-term unresolved inflammation has been suggested as a risk factor for the development of various malignancies. The goal of this study was to examine whether the expression of interleukin (IL)-16, a proinflammatory cytokine, changes in association with ovarian cancer (OVCA) development.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">interleukin 16</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">malignant transformation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ovarian cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">laying hen model</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bitterman, Pincas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharma, Sameer</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guirguis, Alfred S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bahr, Janice M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Basu, Sanjib</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abramowicz, Jacques S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barua, Animesh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:210</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:2721-27210</subfield><subfield code="g">extent:24490</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2013.12.041</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">210</subfield><subfield code="j">2014</subfield><subfield code="e">3</subfield><subfield code="h">2721-27210</subfield><subfield code="g">24490</subfield><subfield code="y">210.2014, 3, 272.e1-, (24490 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400591 |